A sane, science-based perspective on public health. Senior Fellow, Consumer Choice Center. Policy advisor: The Heartland Institute. Sr. Fellow, @Protectaxpayers
Sen Chuck Schumer calls Zyn "a pouch packed with problems."
Chuck, your “FACTS" are packed with problems.
@US_FDA says nicotine pouches, benefit people who switch from smoking.
Learn the truth about nicotine pouches:
More from Apelberg on CTP's communications:
“We've really recognized over the past year that increased engagement and communication with applicants is really valuable. In the past we recognize that we've sort of had more minimal interactions with respect to the review process."
Scoop: FDA Acting Commissioner Kyle Diamantas is scheduled to have a closed-door roundtable this week with over a dozen groups advocating for rare disease treatments, according to a senior agency official. https://t.co/pikg8tkenu
I'm just sayin' what every ex-smoker who quit by vaping knows:
This is why non-tobacco flavors matter. ...Unless your real goal is to drive ex-smokers back to deadly cigarettes.
Dear @Support
I think @Algore09algor's X account has been suspended in error. He is an insightful and articulate commentator on tobacco and nicotine policy and science, not a troll, bot or shill. I hope @X will reinstate his account and restore his voice as soon as possible.
The great Milton Friedman said, "One of the great mistakes is to judge policies and programs by their intentions rather than their results.” Interestingly, he wrote a book published in 1980 called 'Free To Choose"
The newly published Tobacco Control Scale 2025 ranks Ireland #1 in Europe for tobacco control policy, yet smoking prevalence in Ireland has remained at around 17% since 2019.
Meanwhile, Sweden is ranked just #24 despite recording the lowest smoking prevalence in Europe, at 3.7% according to the latest CAN data.
If the goal is reducing smoking, surely actual smoking rates should matter more than how restrictive a policy framework looks on paper.
https://t.co/R5YWaR2n4A
Big win in Ohio for natural kratom leaf.
The proposed consent judgment makes clear that natural vegetative kratom is NOT a Schedule I controlled substance under Ohio’s 7-OH rule. Regulators acknowledged that natural kratom leaf contains only trace naturally occurring 7-OH and distinguished it from synthetic/highly concentrated products.
This is exactly what many of us have been saying all along:
Natural kratom leaf ≠ synthetic 7-OH products.
Protect consumers.
Protect lawful businesses.
Target synthetics — not traditional botanical products.
#Kratom #DSHEA #Botanicals #ConsumerSafety #FDA #NaturalProducts #KCPA
Not just e-cig makers. The biggest losers are adult smokers seeking lower risk alternatives. They consistently state their preference for flavors. The reason why— is fascinating — and makes perfect sense.
E-cig makers are criticizing an FDA proposal for how it will evaluate flavored vaping devices, arguing it still makes it challenging to bring more smoke-free alternatives to the market and advance a promise from Trump to save vaping. https://t.co/B5zfoiirZL
1/2 Oh boy! Great opportunity for those who notice a decline in credibility from the scientific establishment (and the monolothic coverage of it). I wonder whether Bloomberg's influence with WHO, health groups in developing countries, funding of US astroturf groups, ...
HIRING ALERT: STAT is looking for a reporter to cover declining trust in science. This reporter will examine the forces eroding the authority of scientific institutions and mainstream medicine. Apply here:
https://t.co/NJ8bhGrfiP
🔎 Important and balanced piece in @bloomberglaw on @FDATobacco's belated, makeshift acknowledgement that flavored vaping helps countless adults to quit smoking and save lives. 1/🧵
https://t.co/P57lZroB6P
I wrote a whole paper on this bit of rhetoric. In short, the only people who talk about the tobacco playbook are those who want to treat things like tobacco. They’re the ones using a playbook. It’s projection. https://t.co/a7DqOOE787